WO1999047062A1 - Systeme de marquage de seringues - Google Patents
Systeme de marquage de seringues Download PDFInfo
- Publication number
- WO1999047062A1 WO1999047062A1 PCT/US1999/005627 US9905627W WO9947062A1 WO 1999047062 A1 WO1999047062 A1 WO 1999047062A1 US 9905627 W US9905627 W US 9905627W WO 9947062 A1 WO9947062 A1 WO 9947062A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lid
- flip top
- top lid
- syringe
- vial
- Prior art date
Links
- 238000002372 labelling Methods 0.000 title claims description 16
- 239000003814 drug Substances 0.000 claims abstract description 75
- 229940079593 drug Drugs 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000002483 medication Methods 0.000 claims description 13
- 238000007789 sealing Methods 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 239000003086 colorant Substances 0.000 claims description 4
- 210000005069 ears Anatomy 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 239000000975 dye Substances 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 239000004033 plastic Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 235000012489 doughnuts Nutrition 0.000 description 4
- 238000009434 installation Methods 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004081 narcotic agent Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 2
- 229960003556 aminophylline Drugs 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229930003347 Atropine Natural products 0.000 description 1
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229940015042 glycopyrrolate Drugs 0.000 description 1
- 239000001046 green dye Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- GVEAYVLWDAFXET-XGHATYIMSA-N pancuronium Chemical compound C[N+]1([C@@H]2[C@@H](OC(C)=O)C[C@@H]3CC[C@H]4[C@@H]5C[C@@H]([C@@H]([C@]5(CC[C@@H]4[C@@]3(C)C2)C)OC(=O)C)[N+]2(C)CCCCC2)CCCCC1 GVEAYVLWDAFXET-XGHATYIMSA-N 0.000 description 1
- 229960005457 pancuronium Drugs 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/582—Means for facilitating use, e.g. by people with impaired vision by tactile feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
Definitions
- containers and more particularly to the labeling of syringes containing medication.
- the invention provides in one aspect a method for the identification of a syringe containing medication comprising the steps of: mounting and then sealing
- the invention provides in another aspect a flip top lid for labeling or identifying the contents of a syringe of a type which withdraws medication from a vial or the like.
- the flip top lid comprises an inner surface and an outer surface, with the lid having a label for displaying information of the medicine in the vial on 3 one of the surfaces.
- the lid further comprises attachment means for mounting the lid onto a plunger base of the syringe whereby the label containing the information is displayed upon the syringe.
- the invention provides in yet another aspect a flip top lid for labeling the contents of a syringe, the flip top lid comprising: an inner surface and an outer surface; the inner surface comprising attachment means for sealing said lid to a
- said lid having means for mounting said lid onto said plunger base of said syringe whereby said tactile indicia
- FIG. 1 is a schematic perspective view of a conventional syringe assembly and conventional medicine vial and a label cap of the present invention
- FIG. 2 is a schematic perspective view of the label cap mounted on the syringe assembly as shown in FIG. 1; 4 FIG. 3 is a side elevational view of the label cap mounted on the syringe assembly as shown in FIG. 2;
- FIG. 4 is a cross sectional view in the direction 4-4 of the assembly as shown in FIG. 3;
- FIGS. 5A-5H show substantially enlarged perspective views of a label cap having a tactile identification system of the present invention
- FIG. 6 is a side elevational view of an alternative embodiment of a label cap
- FIG. 7 is a schematic perspective view of an alternative embodiment of the
- FIG. 8 is a side elevational view of the label cap as shown in FIG. 6 mounted on the syringe assembly;
- FIG. 9 is a schematic perspective view of an alternative embodiment of a
- FIG. 10 is a schematic perspective view of an alternative embodiment of a
- FIG. 11 is a schematic perspective view of an alternative embodiment of a label cap of the present invention.
- FIG. 12 is a schematic perspective view of an alternative embodiment of a label cap of the present invention.
- FIG. 13 is a schematic perspective view of an alternative embodiment of a label cap of the present invention. 5 Detailed Description Of Preferred And Alternate Embodiments
- FIGS. 1 and 2 there is shown a typical hypodermic syringe generally indicated at 10, which is very well known in
- the syringe 10 comprises a cylindrical barrel 12 having a flanged opening 14 and a needle 16 extending from a distal end of the barrel 12.
- a slidable plunger 20 is inserted inside the flanged opening 14 of barrel 12.
- the plunger 20 comprises
- the vial 30 contains a
- the top portion 34 of the vial 30 contains a flip top
- lid 40 in the shape of a flat disc and having a rim 42 on the outer periphery which
- the rubber seal 36 of the medicine vial allows the insertion of a syringe needle
- the flip top lid 40 is affixed to the top portion 34 of the medicine vial 30 by a metal or plastic seal 38 shaped to conform to the top portion of the vial.
- underside surface 41 of the flip top lid 40 contains a circular boss 44 about which the metal or plastic seal 38 is affixed thereto.
- flip top lid 40 forms a contiguous seal over the top surface of the vial 30 in order to protect the rubber seal 36 from exposure to the elements and form a tamper resistant
- the metal seal 38 has a frangible circular portion 39 surrounding the
- FIG. 1 Another type of prior art flip top lid 6 (not shown) comprises a circular array of legs instead of a boss, and the array of legs are inserted down and between the rubber seal and the underside of the metal ring 38 whereby the rubber seal is protected.
- the flip top lid 40 is
- the rubber seal 38 is exposed and ready for insertion of a syringe needle 16 therein.
- the flip top lid 40 of the present invention has dual utility, in that it protects the
- the flip top lid may
- the lid 40 may be easily installed upon the plunger base 24 of a conventional syringe
- the flip top lid 40 may further comprise
- attachment means such as a clip 50.
- the flip top lid is inverted and clipped to a rib 22 of the plunger 20 by the clip 50.
- the clip 50 may
- the clip comprises an arm 52 which extends orthogonally from the flip top lid 40 at a length sufficient to clear the height
- Gripping means 56 on the distal end of the arm 52 further comprise a slot 54 for receiving and clamping the rib 22 in order to secure the flip
- top lid 40 to the plunger base 24. Once installed upon the plunger base 24, the flip 7 top lid 40 displays a label 60, which contains the necessary information to label the syringe such as drug name and concentration.
- the flip top lid 40 may be made of plastic or any other suitable material, and
- the flip top lid 40 be made of colored plastic, with a designated color
- the color red may represent muscle
- the color green may represent atropine/glycopyrrolate or other
- the color blue may represent narcotics
- the color yellow may
- the color white may represent heparin, the color
- lavender may represent cardiac pressers, and the color black may represent any
- the invention may additionally comprise the color coding of the medication
- inert colored dyes are other labeling methods as described herein.
- inert colored dyes are other labeling methods as described herein.
- an inert red dye may be added to muscle relaxants
- an inert 8 green dye may be added to antisialagogues
- an inert blue dye may be added to narcotics
- a yellow inert dye may be added to induction agents
- a inert white dye may be added to heparin
- an inert lavender dye may be added to cardiac pressers
- a black dye may be added to any toxic agent such as potassium or
- the inert dyes are preferably added to the drugs during the manufacturing stage to reduce costs.
- the inert dyes may comprise any suitable
- the flip top lid 40 may also preferably comprise a tactile identification
- sharp spikes 120 in series would represent Pancuronium as shown in FIG. 5A
- two dull ridges 122 would represent antisialagogues as shown in FIG. 5B
- a single dull ridge 124 would represent narcotics as shown in FIG. 5C
- a raised star-like pattern 126 would represent induction agents as shown in FIG. 5D
- a pair of concentric ridges 130 may be used to represent cardiac pressers as shown in FIG. 5F, a raised circular projection 132 may represent insulin
- the tactile features are raised surface projections, and have a raised height on the order of about 1-5 millimeters.
- the flip top lid may be formed during the manufacture of the flip top lid such as by injection
- FIGS. 6-8 show an alternate embodiment of the flip top lid 70 of the present invention.
- the alternative embodiment of the flip top lid 70 comprises a
- Each leg 74 has a hooked distal end 76 of a sufficient length to fit snugly around the base 24 of the plunger 20 on the syringe 10
- flip top lid 70 is removed from the medicine vial in the conventional manner to break the seal 38 and unseat the hooked distal ends 76 of the legs 74.
- the flip top lid 70 containing a label 60 to identify the drug type and concentration and any other
- the hooked distal ends 76 of the flip top lid 70 are snapped onto the base 24 of the plunger 20 such that the hooked ends operate to securely fasten or latch the flip top lid 70 onto the plunger base 24. In order to accomplish this, it is
- the flip top lid 70 comprise a sufficiently resilient plastic or other
- the flip top lid 70 may also optionally be color coded and may
- the flip top lid 70 may be optionally used in conjunction with the color coding of medications as described earlier.
- Figure 9 shows an additional embodiment of the flip top lid.
- the flip top lid 80 comprises a planar top surface 82 upon which the label 60 or
- tactile identification system may be indicated thereon, and an extended circumferential collar 84 having a plurality of undercuts 86 located along the interior 10 surface of the collar 84.
- the height of the collar 84 is sufficient to fit onto a conventional medicine vial 30.
- the top surface of the flip top lid 80 may also be indicated thereon, and an extended circumferential collar 84 having a plurality of undercuts 86 located along the interior 10 surface of the collar 84.
- the height of the collar 84 is sufficient to fit onto a conventional medicine vial 30.
- the top surface of the flip top lid 80 may also be indicated thereon, and an extended circumferential collar 84 having a plurality of undercuts 86 located along the interior 10 surface of the collar 84.
- the height of the collar 84 is sufficient to fit onto a conventional medicine vial 30.
- the top surface of the flip top lid 80 may also be indicated thereon, and an extended circumferential collar 84 having a plurality of undercuts 86 located along the interior 10 surface of the collar
- the flip top lid 80 may be molded from a suitable material
- the underside of the flip top lid 80 comprises a conventional boss 44 or other attachment
- the flip top lid 80 containing the label 60 may now be installed easily by the user upon the plunger base 24 of a syringe 10. A slight force is needed by the user to install the flip top lid 80 over the plunger base 24.
- undercuts 86 of the lid 80 secure the lid to the plunger base 24 and are spaced to
- the flip top lid 80 may also optionally be color coded and may also optionally contain the raised tactile
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- the flip top lid 80 may be any type of identification system, as described above.
- Figure 10 shows a slight variation of the flip top lid 80 as shown in Figure 9, except the collar has a plurality of cut-outs 88 forming a plurality of sections which
- the cutouts 88 also allow for easier installation upon the plunger base 24. Slots 85 may also be optionally formed upon the top surface 82 of the lid 80.
- the flip top lid 80 may also optionally be 11 color coded and may also optionally contain the raised tactile identification system,
- the flip top lid 80 may be optionally used in conjunction with the color coding of medications as described earlier.
- Figure 11 shows an alternative embodiment of the flip top lid 80 shown in
- flip top lid 80 does not have undercuts 86.
- the flip top lid 80 instead has two opposed slots 90 located on the collar 84.
- extensions 92 are aligned with the slots 90 of the lid 80 and then the user exerts a
- the flip top lid 80 may also optionally be color coded and may also optionally contain the raised tactile
- the flip top lid 80 may also be optionally used in conjunction with the color coding of medications as described
- Figure 12 shows still another embodiment of the flip top lid 100 comprising a planar disc upper surface 102 having a label 60 and a boss 44 or other attachment
- the lid 100 further comprises a pair of dog ears 102 which fold down for installation onto a pair of opposed male pins 104 on the plunger base 24.
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as 12 described above. In addition, the flip top lid 100 may be optionally used in conjunction with the color coding of medications as described earlier.
- Figure 13 is yet another embodiment of the flip top lid 100 comprising a
- planar disc upper surface 102 having a label 60 and a boss 44 or other attachment
- the lid 100 further comprises a pair of orthogonal opposed male pins 110 which are
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above.
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above.
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above.
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above.
- the flip top lid 100 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above.
- a conventional or prior art flip top lid 120 is modified by adding a donut shaped ring 122 on the interior side of the
- the donut shaped ring 122 comprises a layer of adhesive or glue with a sufficient bonding strength to adhere the lid 120 to a syringe
- the layer of adhesive is protected by a layer of material which is
- This donut shaped ring 122 must have a height the same or greater than the boss 44 or sealing means for proper bonding to the syringe plunger base 24.
- the donut shaped ring 122 may be molded or made by other conventional ways known in the
- the flip top lid 120 may also optionally be color coded and may also optionally contain the raised tactile identification system, as described above. In 13 addition, the flip top lid 120 may be optionally used in conjunction with the color coding of medications as described earlier.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
L'invention concerne un procédé et un appareil permettant d'identifier des seringues renfermant un médicament, à l'aide d'un couvercle encliquetable pourvu d'un marquage et pouvant être retiré de flacons de médicaments traditionnels pour être facilement installé sur la base du piston de la seringue. Ce couvercle encliquetable peut également comprendre un système de codage par couleurs, et/ou une caractéristique tactile surélevée sur la surface extérieure pour faciliter l'identification du médicament. En outre, le médicament lui-même peut être marqué à l'aide d'un système de codage par couleurs pour faciliter l'identification des seringues.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7857098P | 1998-03-17 | 1998-03-17 | |
US60/078,570 | 1998-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999047062A1 true WO1999047062A1 (fr) | 1999-09-23 |
Family
ID=22144903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/005627 WO1999047062A1 (fr) | 1998-03-17 | 1999-03-17 | Systeme de marquage de seringues |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1999047062A1 (fr) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002011664A1 (fr) * | 2000-08-03 | 2002-02-14 | Novo Nordisk A/S | Codage d'un dispositif medical |
GB2380467A (en) * | 2001-10-02 | 2003-04-09 | Helen Clough | Removable, reusable drug dispenser label system |
WO2003107307A1 (fr) * | 2002-06-18 | 2003-12-24 | Spear U.S.A., L.L.C. | Etiquette adhesive a revetement a sensation tactile |
WO2010112565A1 (fr) * | 2009-03-31 | 2010-10-07 | Sanofi-Aventis Deutschland Gmbh | Bouton doseur pour dispositif d'administration de médicament et procédé de fabrication d'un bouton doseur |
WO2011089204A3 (fr) * | 2010-01-22 | 2011-09-22 | Sanofi-Aventis Deutschland Gmbh | Identificateur multidimensionnel |
WO2011121003A1 (fr) * | 2010-03-31 | 2011-10-06 | Sanofi-Aventis Deutschland Gmbh | Ensemble de dispositifs d'administration de médicament comportant des améliorations tactiles ou visuelles |
WO2011138316A1 (fr) * | 2010-05-04 | 2011-11-10 | Sanofi-Aventis Deutschland Gmbh | Identification tactile de cartouche remplie de médicament |
EP2391407A2 (fr) * | 2008-12-30 | 2011-12-07 | Medtronic MiniMed, Inc. | Système de détection de couleur destiné à détecter la présence et le contenu d un réservoir dans un dispositif |
US20120101445A1 (en) * | 2009-01-23 | 2012-04-26 | Sanofi-Aventis Deutschland Gmbh | Medicament Identification System for Multi-Dose Injection Devices |
EP2359881A4 (fr) * | 2008-12-16 | 2013-04-17 | Panasonic Corp | Dispositif d'administration de médicament |
US8657793B2 (en) | 2011-09-30 | 2014-02-25 | Becton Dickinson France, S.A.S | Space saving plunger cap and rod assembly |
WO2018156336A1 (fr) * | 2017-02-23 | 2018-08-30 | Smiths Medical Asd, Inc. | Dispositif doté d'un identifiant |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2190606A (en) * | 1938-04-07 | 1940-02-13 | Gen Motors Corp | Bottle cap |
US2665024A (en) * | 1951-01-15 | 1954-01-05 | Baxter Don Inc | Pharmaceutical closure |
US3233727A (en) * | 1963-09-13 | 1966-02-08 | Karl H Wilson | Multiple use packaging container |
US3312365A (en) * | 1963-08-07 | 1967-04-04 | Minnesota Mining & Mfg | Cap liner |
US5001032A (en) * | 1988-02-08 | 1991-03-19 | Canon Kabushiki Kaisha | Photosensitive material containing a photosensitive and heat developable element and a polymerizable layer and image-forming method utilizing the same |
-
1999
- 1999-03-17 WO PCT/US1999/005627 patent/WO1999047062A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2190606A (en) * | 1938-04-07 | 1940-02-13 | Gen Motors Corp | Bottle cap |
US2665024A (en) * | 1951-01-15 | 1954-01-05 | Baxter Don Inc | Pharmaceutical closure |
US3312365A (en) * | 1963-08-07 | 1967-04-04 | Minnesota Mining & Mfg | Cap liner |
US3233727A (en) * | 1963-09-13 | 1966-02-08 | Karl H Wilson | Multiple use packaging container |
US5001032A (en) * | 1988-02-08 | 1991-03-19 | Canon Kabushiki Kaisha | Photosensitive material containing a photosensitive and heat developable element and a polymerizable layer and image-forming method utilizing the same |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002011664A1 (fr) * | 2000-08-03 | 2002-02-14 | Novo Nordisk A/S | Codage d'un dispositif medical |
GB2380467A (en) * | 2001-10-02 | 2003-04-09 | Helen Clough | Removable, reusable drug dispenser label system |
WO2003107307A1 (fr) * | 2002-06-18 | 2003-12-24 | Spear U.S.A., L.L.C. | Etiquette adhesive a revetement a sensation tactile |
US7090907B2 (en) | 2002-06-18 | 2006-08-15 | Spear Usa, Llc | Adhesive coated label having tactile feel |
EP2359881A4 (fr) * | 2008-12-16 | 2013-04-17 | Panasonic Corp | Dispositif d'administration de médicament |
US8771233B2 (en) | 2008-12-16 | 2014-07-08 | Atsushi Watanabe | Medication administering device |
EP2391407A2 (fr) * | 2008-12-30 | 2011-12-07 | Medtronic MiniMed, Inc. | Système de détection de couleur destiné à détecter la présence et le contenu d un réservoir dans un dispositif |
US20120101445A1 (en) * | 2009-01-23 | 2012-04-26 | Sanofi-Aventis Deutschland Gmbh | Medicament Identification System for Multi-Dose Injection Devices |
JP2012515585A (ja) * | 2009-01-23 | 2012-07-12 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 反復投与注入デバイス用の医薬品識別システム |
WO2010112565A1 (fr) * | 2009-03-31 | 2010-10-07 | Sanofi-Aventis Deutschland Gmbh | Bouton doseur pour dispositif d'administration de médicament et procédé de fabrication d'un bouton doseur |
US10286150B2 (en) | 2009-03-31 | 2019-05-14 | Michael Harms | Dose button for a drug delivery device and method for manufacturing a dose button |
JP2012521836A (ja) * | 2009-03-31 | 2012-09-20 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬物送達デバイス用の投与ボタン及び投与ボタンの製造方法 |
AU2011208651B2 (en) * | 2010-01-22 | 2015-06-11 | Sanofi-Aventis Deutschland Gmbh | A multi-dimensional identifier |
WO2011089204A3 (fr) * | 2010-01-22 | 2011-09-22 | Sanofi-Aventis Deutschland Gmbh | Identificateur multidimensionnel |
CN102711711A (zh) * | 2010-01-22 | 2012-10-03 | 赛诺菲-安万特德国有限公司 | 多维标识物 |
US9375386B2 (en) | 2010-01-22 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Multi-dimensional identifier |
WO2011121003A1 (fr) * | 2010-03-31 | 2011-10-06 | Sanofi-Aventis Deutschland Gmbh | Ensemble de dispositifs d'administration de médicament comportant des améliorations tactiles ou visuelles |
US10207056B2 (en) | 2010-03-31 | 2019-02-19 | Sanofi-Aventis Deutschland Gmbh | Set of members for a drug delivery device, drug delivery device and set of drug delivery devices |
US20130072879A1 (en) * | 2010-03-31 | 2013-03-21 | Sanofi-Aventis Deutschland Gmbh | Set of members for a drug delivery device, drug delivery device and set of drug delivery devices |
WO2011138316A1 (fr) * | 2010-05-04 | 2011-11-10 | Sanofi-Aventis Deutschland Gmbh | Identification tactile de cartouche remplie de médicament |
JP2013529944A (ja) * | 2010-05-04 | 2013-07-25 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 薬物充填カートリッジの触覚的識別 |
US8657793B2 (en) | 2011-09-30 | 2014-02-25 | Becton Dickinson France, S.A.S | Space saving plunger cap and rod assembly |
WO2018156336A1 (fr) * | 2017-02-23 | 2018-08-30 | Smiths Medical Asd, Inc. | Dispositif doté d'un identifiant |
GB2572122A (en) * | 2017-02-23 | 2019-09-18 | Smiths Medical Asd Inc | Device with identifier |
GB2572122B (en) * | 2017-02-23 | 2022-05-11 | Smiths Medical Asd Inc | Device with identifier |
US11783933B2 (en) | 2017-02-23 | 2023-10-10 | Smiths Medical Asd, Inc. | Device with identifier |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4884584B2 (ja) | 瓶および医療容器用の移送セット | |
CA2921633C (fr) | Capuchon pour un recipient | |
US4929232A (en) | Syringe having tamper evidence features | |
KR102789526B1 (ko) | 의료용 주사 장치를 위한 팁 캡 | |
WO1999047062A1 (fr) | Systeme de marquage de seringues | |
US7488307B2 (en) | Security assembly for fitting to a syringe, and a syringe assembly | |
EP0765652B1 (fr) | Ensemble du conteneur refermable ayant une membrane et un poussoir | |
CA2794052C (fr) | Systeme de securite pour injection | |
JP4300116B2 (ja) | 容器とコンテナとの間を接続するためのデバイスおよびこのデバイスを備えるすぐに使用可能なアセンブリ | |
US5702019A (en) | Vial having resealable membrane assembly activated by a medical delivery device | |
EP0227890B1 (fr) | Seringue hypodermique comprenant une enveloppe de protection | |
US4832695A (en) | Tamper evident injection syringe | |
US4449640A (en) | Tamper-resistant pharmaceutical vial and cap assembly | |
US4420092A (en) | Tamper-resistant pharmaceutical vial and cap assembly | |
US20170087305A1 (en) | Tamper Evident Needle Guard for Syringes | |
ES2755758T3 (es) | Conjunto de tapa de punta de jeringa, jeringa que comprende dicha tapa de punta de jeringa y método para obturar un cilindro de jeringa | |
US11981484B2 (en) | Labelling arrangement for a multi-part container, system and method for applying a labelling arrangement to a multi-part container | |
US20020128629A1 (en) | Device for connection between a recipient and a container, and ready-to-use assembly comprising such a device | |
US11872187B1 (en) | Tamper evident seal for a vial cover | |
US20180169340A1 (en) | Method for producing at least one reservoir assembly, injectable-product reservoir assembly for an injection pen and injection pen equipped with such an assembly | |
JP3767712B2 (ja) | 改ざん防止ラベル | |
US20180272071A1 (en) | System and Method for Associating a Syringe with a Corresponding Vial and Medicinal Composition | |
DE60121641T2 (de) | Verschlusskappe für Behälter | |
US20220118190A1 (en) | Impact resistant and tamper evident system for prefilled syringe | |
Cohen | Bad connection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09646514 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |